ENTRADA
Live / Registered — Registered (as of 07 Jul 2026)
What this means for you
Registered since 07 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Jul 2032: the §8 declaration of use).
Record
- Serial number
- 99544818
- Registration number
- 8333092
- Mark type
- Word mark
- Filed
- 12 Dec 2025
- Published for opposition
- 19 May 2026
- Registered
- 07 Jul 2026
- Next maintenance filing
- §8 declaration of use, due by 07 Jul 2032 (grace period to 07 Jan 2033)
- Attorney of record
- Stephanie H. Bald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for human use, namely, pharmaceuticals for prevention and treatment of diseases and conditions mediated via intracellular transport processes, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; all of the foregoing specifically excluding pharmaceutical preparations for the treatment of cancer
- Class 042 — Scientific and technological services: Pharmaceutical research and development services
Owner
- Entrada Therapeutics, Inc., Boston, MA, US
- Entrada Therapeutics, Inc., Boston, MA, US
- Entrada Therapeutics, Inc., Boston, MA, US
Prior registrations
Prosecution history
- 07 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
- 19 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 May 2026 — PUBLISHED FOR OPPOSITION
- 13 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Apr 2026 — ASSIGNED TO EXAMINER
- 14 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 12 Dec 2025 — NEW APPLICATION ENTERED